LUMO

Lumos Pharma, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website lumos-pharma.com
Employees(FY) 32
ISIN US55028X1090

Performance

-15.89%

1W

+0.79%

1M

-14.19%

3M

-15.33%

6M

-20.13%

YTD

-21.85%

1Y

Profile

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its primary product candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 3 clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.

Advanced Technical Analysis

Technical Analysis of LUMO 2024-05-10

Overview:

In analyzing the technical indicators for LUMO stock over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible future stock price movement. By examining key indicators such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to offer valu...

See more ...

Recent News & Updates

2024-05-15 15:02
Lumos Pharma Inc (LUMO) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial ...(Yahoo Finance)
2024-05-14 10:53
LUMO Stock Earnings: Lumos Pharma Misses EPS, Misses Revenue for Q1 2024(Investorplace)
2024-05-14 04:15
Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results(Globenewswire)
2024-05-09 02:51
Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024(Globenewswire)
2024-04-18 04:05
Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings(Globenewswire)
2024-03-19 20:00
Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042(Globenewswire)
2024-03-08 01:06
Lumos Pharma, Inc. (NASDAQ:LUMO) Q4 2023 Earnings Call Transcript(Insidermonkey)
2024-03-07 08:54
LUMO Stock Earnings: Lumos Pharma Misses EPS for Q4 2023(Investorplace)
2024-03-07 03:01
Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update(Globenewswire)
2024-02-25 20:00
Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024(Globenewswire)
2024-02-05 03:05
Lumos Pharma to Participate in Oppenheimer's 34th Annual Healthcare Life Sciences Conference(Globenewswire)
2024-01-04 03:05
Lumos Pharma Promotes Pisit Duke Pitukcheewanont, MD to Chief Medical Officer(Globenewswire)
2023-11-21 03:15
Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency(Globenewswire)
2023-11-20 03:05
Lumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in November(Globenewswire)
2023-11-07 03:35
Lumos Pharma Reports Third Quarter 2023 Financial Results and Clinical Development Updates(Globenewswire)
2023-11-07 03:01
Lumos Pharma Announces Topline Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials of LUM-201 in PGHD Met All Primary and Secondary Endpoints(Globenewswire)
2023-09-25 21:00
Lumos Pharma Announces New Data and Analysis of 15 Subjects from OraGrowtH212 Trial Presented at the 2023 ESPE Annual Meeting(Yahoo Finance)
2023-09-13 20:00
Lumos Pharma Announced Abstract Accepted for Oral Presentation at the European Society for Paediatric Endocrinology Annual Meeting(Yahoo Finance)
2023-09-07 04:34
Lumos Pharma Announces Participation in Investor Conferences in September(Yahoo Finance)
2023-08-21 21:00
Independent Panel of Renowned Pediatric Endocrinologists to Discuss Pediatric Growth Hormone Deficiency and the Therapeutic Landscape(Yahoo Finance)
2023-08-09 04:01
Lumos Pharma Reports Second Quarter 2023 Financial Results, Provides Clinical Update(Yahoo Finance)
2023-07-25 21:00
Lumos Pharma to Report Second Quarter 2023 Financial Results and Host Conference Call on August 9, 2023(Yahoo Finance)
2023-07-11 20:00
Lumos Pharma to Participate in the Oppenheimer 2023 Montauk Life Sciences Summit(Yahoo Finance)
2023-06-28 04:01
Lumos Pharma Announces Departure of Chief Medical Officer(Yahoo Finance)
2023-06-20 21:00
Lumos to Highlight New LUM-201 Data and Analysis Presented at ENDO 2023 in Virtual KOL Webinar(Yahoo Finance)
2023-05-30 20:00
Lumos Pharma to Participate in the Upcoming 2023 BIO International Convention and the Jefferies Healthcare Conference(Yahoo Finance)
2023-05-24 20:00
Lumos Pharma Announces Abstracts Accepted for Oral Presentation at 2023 ENDO Meeting with Virtual KOL Event to be Held on June 21st(Yahoo Finance)
2023-05-21 21:00
Lumos Pharma to Participate in World Orphan Drug Congress USA(Yahoo Finance)
2023-05-07 20:00
Encouraging Data from Lumos Pharma OraGrowtH Trials Presented at Annual Pediatric Endocrine Society Meeting (PES)(Yahoo Finance)
2023-05-03 04:05
Lumos Pharma Reports First Quarter 2023 Financial Results, Provides Clinical Updates(Yahoo Finance)

Page 1 of 4

previousnext